Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy

Neuro Oncol. 2021 Nov 2;23(11):1974-1976. doi: 10.1093/neuonc/noab184.

Calixto-Hope G Lucas¹, Sabine Mueller^{2

3

4}, Alyssa Reddy^{1

4}, Jennie W Taylor^{3

5}, Nancy Ann Oberheim Bush^{3

5}, Jennifer L Clarke^{3

5}, Susan M Chang^{3

5}, Nalin Gupta⁶, Mitchel S Berger⁴, Arie Perry^{1

4}, Joanna J Phillips^{1

4}, David A Solomon¹

¹ Department of Pathology, University of California, San Francisco, San Francisco, California, USA.
² Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA.
³ Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
⁴ Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
⁵ Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
⁶ Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA.

No abstract available

Publication types